Epigenetics is drawing a lot of attention in recent years, driven by recent advances in science and technology. Efforts to unravel the epigenome and a deeper understanding of the role epigenetic pathways play in cell function and disease have led to intense drug-discovery initiatives both in academia and the pharma/biotech industry. The Scientist brings together a panel of experts to address some of the key questions that the field is grappling with today. Attendees can interact with the expert panelists during the live webinar by asking pertinent questions and sharing their experiences in epigenetics research.
Topics To Be Covered:
- Do we have a good understanding of the mechanisms underlying epigenetics?
- Do we have the right in vitro assays, screening platforms, and in vivo models?
- How do we tackle the concerns about safety and adverse events?
- Case studies highlighting current challenges and opportunities
Meet the Speakers:
Dr. Margaret Porter-Scott
Senior Director, Lead Discovery
Dr. Jatinder Singh
Principal Scientist, Drug Safety and Metabolism
AstraZeneca Pharmaceuticals (speaking independently of AstraZeneca)